Assessing response, remission, and treatment resistance in patients with obsessive-compulsive disorder with and without tic disorders: results from a multicenter study.

Obsessive–compulsive disorder psychopharmacology remission response tic disorder treatment resistance

Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 17 9 2021
medline: 7 12 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

Highlighting the relationship between obsessive-compulsive disorder (OCD) and tic disorder (TD), two highly disabling, comorbid, and difficult-to-treat conditions, Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) acknowledged a new "tic-related" specifier for OCD, ie, obsessive-compulsive tic-related disorder (OCTD). As patients with OCTD may frequently show poor treatment response, the aim of this multicenter study was to investigate rates and clinical correlates of response, remission, and treatment resistance in a large multicenter sample of OCD patients with versus without tics. A sample of 398 patients with a DSM-5 diagnosis of OCD with and without comorbid TD was assessed from 10 different psychiatric departments across Italy. For the purpose of the study, treatment response profiles in the whole sample were analyzed comparing the rates of response, remission, and treatment-resistance as well as related clinical features. Multivariate logistic regressions were performed to identify possible factors associated with treatment response. The remission group was associated with later ages of onset of TD and OCD. Moreover, significantly higher rates of psychiatric comorbidities, TD, and lifetime suicidal ideation and attempts emerged in the treatment-resistant group, with larger degrees of perceived worsened quality of life and family involvement. Although remission was associated with later ages of OCD and TD onset, specific clinical factors, such as early onset and presence of psychiatric comorbidities and concomitant TD, predicted a worse treatment response with a significant impairment in quality of life for both patients and their caregivers, suggesting a worse profile of treatment response for patients with OCTD.

Sections du résumé

BACKGROUND
Highlighting the relationship between obsessive-compulsive disorder (OCD) and tic disorder (TD), two highly disabling, comorbid, and difficult-to-treat conditions, Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) acknowledged a new "tic-related" specifier for OCD, ie, obsessive-compulsive tic-related disorder (OCTD). As patients with OCTD may frequently show poor treatment response, the aim of this multicenter study was to investigate rates and clinical correlates of response, remission, and treatment resistance in a large multicenter sample of OCD patients with versus without tics.
METHODS
A sample of 398 patients with a DSM-5 diagnosis of OCD with and without comorbid TD was assessed from 10 different psychiatric departments across Italy. For the purpose of the study, treatment response profiles in the whole sample were analyzed comparing the rates of response, remission, and treatment-resistance as well as related clinical features. Multivariate logistic regressions were performed to identify possible factors associated with treatment response.
RESULTS
The remission group was associated with later ages of onset of TD and OCD. Moreover, significantly higher rates of psychiatric comorbidities, TD, and lifetime suicidal ideation and attempts emerged in the treatment-resistant group, with larger degrees of perceived worsened quality of life and family involvement.
CONCLUSIONS
Although remission was associated with later ages of OCD and TD onset, specific clinical factors, such as early onset and presence of psychiatric comorbidities and concomitant TD, predicted a worse treatment response with a significant impairment in quality of life for both patients and their caregivers, suggesting a worse profile of treatment response for patients with OCTD.

Identifiants

pubmed: 34528504
doi: 10.1017/S109285292100081X
pii: S109285292100081X
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-753

Auteurs

Beatrice Benatti (B)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.
"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.

Nicolaja Girone (N)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.

Dario Conti (D)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.

Rita Cafaro (R)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.

Caterina Viganò (C)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.

Matteo Briguglio (M)

IRCCS Orthopedic Institute Galeazzi Department of Functional Neurosurgery, Tourette Center, Milan, Italy.

Donatella Marazziti (D)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Federico Mucci (F)

Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.

Orsola Gambini (O)

"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.
Department of Health Sciences, University of Milan, Milan, Italy.

Benedetta Demartini (B)

"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.
Department of Health Sciences, University of Milan, Milan, Italy.

Antonio Tundo (A)

Institute of Psychopathology, Rome, Italy.

Roberta Necci (R)

Institute of Psychopathology, Rome, Italy.

Domenico De Berardis (D)

Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", NHS, Teramo, Italy.
Department of Neuroscience, Imaging and Clinical Science, Chair of Psychiatry, University "G. D'Annunzio", Chieti, Italy.

Roberta Galentino (R)

IRCCS Orthopedic Institute Galeazzi Department of Functional Neurosurgery, Tourette Center, Milan, Italy.

Sara De Michele (S)

IRCCS Orthopedic Institute Galeazzi Department of Functional Neurosurgery, Tourette Center, Milan, Italy.

Roberta Balestrino (R)

Università Vita-Salute San Raffaele, Milano, Italy.

Umberto Albert (U)

Dipartimento Universitario Clinico di Scienze Mediche Chirurgiche e della Salute, Università degli Studi di Trieste, Trieste, Italy.
SC Clinica Psichiatrica, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Trieste, Italy.

Sylvia Rigardetto (S)

San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Giuseppe Maina (G)

San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Giacomo Grassi (G)

Brain Center Firenze, Florence, Italy.

Stefano Pallanti (S)

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.

Andrea Amerio (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Andrea Aguglia (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Davide Prestia (D)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Mario Amore (M)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Alberto Priori (A)

"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.
Department of Health Sciences, University of Milan, Milan, Italy.

Domenico Servello (D)

IRCCS Orthopedic Institute Galeazzi Department of Functional Neurosurgery, Tourette Center, Milan, Italy.

Mauro Porta (M)

IRCCS Orthopedic Institute Galeazzi Department of Functional Neurosurgery, Tourette Center, Milan, Italy.

Bernardo Dell'Osso (B)

Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.
"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.
Centro per lo studio dei meccanismi molecolari alla base delle patologie neuro-psico-geriatriche", University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH